SI1651223T1 - Tartratne soli 2-metoksimetil-3-(3,4-diklorofenil)-8- azabiciklo(3.2.1)oktana - Google Patents

Tartratne soli 2-metoksimetil-3-(3,4-diklorofenil)-8- azabiciklo(3.2.1)oktana

Info

Publication number
SI1651223T1
SI1651223T1 SI200430267T SI200430267T SI1651223T1 SI 1651223 T1 SI1651223 T1 SI 1651223T1 SI 200430267 T SI200430267 T SI 200430267T SI 200430267 T SI200430267 T SI 200430267T SI 1651223 T1 SI1651223 T1 SI 1651223T1
Authority
SI
Slovenia
Prior art keywords
åoctane
azabicyclo
dichlorophenyl
methoxymethyl
tartrate salts
Prior art date
Application number
SI200430267T
Other languages
English (en)
Inventor
Brian Frostrup
Frank Watjen
Klaus Snej Jensen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of SI1651223T1 publication Critical patent/SI1651223T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SI200430267T 2003-07-31 2004-07-29 Tartratne soli 2-metoksimetil-3-(3,4-diklorofenil)-8- azabiciklo(3.2.1)oktana SI1651223T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200301117 2003-07-31
US49409003P 2003-08-12 2003-08-12
PCT/EP2004/051651 WO2005011694A1 (en) 2003-07-31 2004-07-29 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts
EP04766360A EP1651223B1 (en) 2003-07-31 2004-07-29 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts

Publications (1)

Publication Number Publication Date
SI1651223T1 true SI1651223T1 (sl) 2007-08-31

Family

ID=36701727

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430267T SI1651223T1 (sl) 2003-07-31 2004-07-29 Tartratne soli 2-metoksimetil-3-(3,4-diklorofenil)-8- azabiciklo(3.2.1)oktana

Country Status (22)

Country Link
US (1) US7700619B2 (sl)
EP (1) EP1651223B1 (sl)
JP (1) JP4711961B2 (sl)
CN (1) CN100427484C (sl)
AR (1) AR045141A1 (sl)
AT (1) ATE355060T1 (sl)
AU (1) AU2004260837C1 (sl)
BR (1) BRPI0413035A (sl)
CA (1) CA2534295A1 (sl)
DE (1) DE602004005048T2 (sl)
DK (1) DK1651223T3 (sl)
ES (1) ES2281827T3 (sl)
MY (1) MY140105A (sl)
NZ (1) NZ544957A (sl)
PL (1) PL1651223T3 (sl)
PT (1) PT1651223E (sl)
RU (1) RU2348631C2 (sl)
SI (1) SI1651223T1 (sl)
TW (1) TW200507844A (sl)
UA (1) UA86025C2 (sl)
WO (1) WO2005011694A1 (sl)
ZA (1) ZA200600756B (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2614833A1 (en) * 2005-07-12 2007-01-18 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising 2, 3-disubstituted tropanes for the treatment of disorders of sexual desire
WO2007028769A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitor for neuroprotection
EP1779851A1 (en) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes
GB0703998D0 (en) 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8923209D0 (en) * 1989-10-14 1989-11-29 Wyeth John & Brother Ltd Heterocyclic compounds
JP3238414B2 (ja) * 1996-02-22 2001-12-17 ニューロサーチ・アクティーゼルスカブ トロパン―誘導体、その製造方法及びその使用方法
WO2003045388A1 (en) * 2001-11-30 2003-06-05 Neurosearch A/S Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases

Also Published As

Publication number Publication date
RU2005141065A (ru) 2006-08-10
JP4711961B2 (ja) 2011-06-29
ES2281827T3 (es) 2007-10-01
EP1651223B1 (en) 2007-02-28
BRPI0413035A (pt) 2006-10-03
WO2005011694A1 (en) 2005-02-10
CA2534295A1 (en) 2005-02-10
AU2004260837C1 (en) 2010-08-19
EP1651223A1 (en) 2006-05-03
TW200507844A (en) 2005-03-01
JP2007509030A (ja) 2007-04-12
US20070043075A1 (en) 2007-02-22
PT1651223E (pt) 2007-03-30
AR045141A1 (es) 2005-10-19
UA86025C2 (en) 2009-03-25
NZ544957A (en) 2009-02-28
AU2004260837A1 (en) 2005-02-10
ATE355060T1 (de) 2006-03-15
MY140105A (en) 2009-11-30
DE602004005048T2 (de) 2007-08-16
CN1822837A (zh) 2006-08-23
DE602004005048D1 (de) 2007-04-12
US7700619B2 (en) 2010-04-20
CN100427484C (zh) 2008-10-22
RU2348631C2 (ru) 2009-03-10
DK1651223T3 (da) 2007-06-11
PL1651223T3 (pl) 2007-07-31
ZA200600756B (en) 2007-05-30

Similar Documents

Publication Publication Date Title
EG23424A (en) Fungicidal azo-carboxamide derivatives.
EG25273A (en) Substituted dihydroquinazolines.
HK1090368A1 (en) 2,3,6-trisubstituted-4-pyrimidone derivatives
ZA200408173B (en) Toothbrush.
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
EP1830858A4 (en) 3,6-BICYCLOLIDE
ZA200409550B (en) Glasses.
ZA200402085B (en) Microbicidal composition.
SI1651223T1 (sl) Tartratne soli 2-metoksimetil-3-(3,4-diklorofenil)-8- azabiciklo(3.2.1)oktana
GB0425572D0 (en) 1,7-Naphthyridines
AP2006003515A0 (en) Fungicidal mixtures.
HK1089968A1 (en) 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo(3.2.1)octane tartrate salts
AP2005003202A0 (en) Dithianon-based fungicidal mixtures.
AP2006003589A0 (en) Fungicidal mixtures.
ZA200205436B (en) Herbicidal methods.
AP2006003547A0 (en) Fungicidal mixtures.
TJ403B (en) Dibaferrol, having antimicrobe activity.
ZA200403502B (en) A toothbrush.
TJ391B (en) Medicinal-preventive biopreparation subtilben.
GB0320813D0 (en) W.R.M et al
ZA200407936B (en) Brush.
ZA200301219B (en) Mattress.
ZA200410277B (en) Mattress.
HK1050417A1 (en) Cassette.
GB0315839D0 (en) www.wereuthe1.com